Pharma Journalist 8916 posts 0 comments

Boehringer Ingelheim and Gubra announced a new research and licensing agreement focused on the identification and validation of targets and innovative peptide compounds for the…
Read More...

Partner Therapeutics, Inc. (PTx) announced top-line results of the investigator-led SARPAC (Sargramostim in Patients with Acute Hypoxic Respiratory Failure and Acute COVID-19) study of…
Read More...

Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, announced the signature of an exclusive license agreement with Merck KGaA, Darmstadt, Germany, a leading…
Read More...

SMi Reports: Exploring the challenges, practices and drivers in the aftermath of the transition for Parallel Trade Join us at SMi’s 15th annual Parallel Trade Conference bringing…
Read More...

Johnson & Johnson (the Company) announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine,…
Read More...

Welldoc, Inc., and Eli Lilly and Company announced a collaboration and licensing agreement to integrate Welldoc's software into Lilly's connected insulin solutions, currently in…
Read More...

Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, announced that the company has been chosen to…
Read More...

SHEPHERD Therapeutics, a company dedicated to catalyzing lifesaving treatments for rare cancer patients, announced a collaboration with the Mayo Clinic to advance research in…
Read More...

Xencor, Inc. a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, and UCLA…
Read More...

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and LYSA-LYSARC-CALYM announced that they have entered a strategic research collaboration to study valemetostat (DS-3201),…
Read More...